Pictet Asset Management (Switzerland)’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $30.1M | Buy |
1,957,120
+406,618
| +26% | +$6.25M | 0.04% | 375 |
|
|
2023
Q1 | $34.9M | Buy |
1,550,502
+995,136
| +179% | +$22.4M | 0.04% | 348 |
|
|
2022
Q4 | $11.7M | Buy |
555,366
+142,855
| +35% | +$3M | 0.02% | 556 |
|
|
2022
Q3 | $10.2M | Buy |
412,511
+59,486
| +17% | +$1.47M | 0.02% | 575 |
|
|
2022
Q2 | $8.55M | Buy |
353,025
+40,479
| +13% | +$981K | 0.01% | 637 |
|
|
2022
Q1 | $8.05M | Sell |
312,546
-19,042
| -6% | -$491K | 0.01% | 696 |
|
|
2021
Q4 | $10.3M | Sell |
331,588
-22,575
| -6% | -$701K | 0.01% | 655 |
|
|
2021
Q3 | $8.59M | Buy |
+354,163
| New | +$8.59M | 0.01% | 704 |
|